[Opinion] Should the 90% CI for GMR be required to encompass 1 [RSABE / ABEL]

posted by jag009  – NJ, 2018-03-29 21:55 (2213 d 03:54 ago) – Posting: # 18619
Views: 9,651

Hi,

❝ Actually, I am questioning the validity of FDA's Swr scaled 10% window on BE for NTID.


❝ If a GMR of 1.1 is clinically relevant (i.e. a test should be sensitive for this), and the NTID with a Swr of .22 will pass by ABE, this is a failure IMO.


Before we go further, does your hypothetical example pass the other two criteria stated in the NTI guidance?

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,653 registered users;
94 visitors (0 registered, 94 guests [including 4 identified bots]).
Forum time: 01:50 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5